Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
177.00    0.00 (0.00%)
Bid:
176.65
Ask:
176.80
Spread: 0.15 (0.085%)
Market Cap: £8.02b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Transaction in Own Shares

16 May 2025 07:00

RNS Number : 9130I
Centrica PLC
16 May 2025
 

Transactions in own shares

 

Centrica plc

16 May 2025

 

Centrica plc announces that it purchased on 15 May 2025 (through Merrill Lynch International) 4,796,475 Centrica plc ordinary shares of 6 14/81 pence each at a price of 148.46 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the extension of the Company's 2024-25 buyback programme announced on 27 December 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Merrill Lynch International as also announced on 27 December 2024, which agreement was subsequently amended as announced on 3 March 2025.

 

Since 3 March 2025, Centrica has purchased 95,758,941 ordinary shares at a cost (excluding dealing and associated costs) of £143,327,715.11.

 

Following the above purchase, Centrica plc holds 518,485,961 ordinary shares in treasury, and has 4,974,621,253 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.

 

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

 

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Merrill Lynch International

Intermediary Code:

MLILGB3LESF

Currency:

GBP

 

Aggregated information

Date of purchase:

15 May 2025

Number of ordinary shares purchased:

4,796,475

Highest price paid:

149.20p

Lowest price paid:

146.05p

Volume weighted average price paid per share:

148.46p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/9130I_1-2025-5-15.pdf

 

END

 

Enquiries:

Investors and Analysts

E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZGMKVKKGKZM
Date   Source Headline
17th Apr 20236:25 pmRNSTransaction in Own Shares
17th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20234:45 pmRNSHolding(s) in Company
12th Apr 20236:25 pmRNSTransaction in Own Shares
12th Apr 20235:00 pmRNSHolding(s) in Company
12th Apr 20232:45 pmRNSDirector/PDMR Shareholding
11th Apr 20236:25 pmRNSTransaction in Own Shares
6th Apr 20236:30 pmRNSTransaction in Own Shares
6th Apr 20234:30 pmRNSHolding(s) in Company
5th Apr 20236:30 pmRNSTransaction in Own Shares
5th Apr 20232:15 pmRNSHolding(s) in Company
5th Apr 20232:00 pmRNSTransfer of Treasury Shares
5th Apr 20237:00 amRNSCommencement of Share Buy-Back Programme
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20235:30 pmRNSDirector/PDMR Shareholding
29th Mar 20236:25 pmRNSTransaction in Own Shares
28th Mar 20236:25 pmRNSTransaction in Own Shares
27th Mar 20236:20 pmRNSTransaction in Own Shares
27th Mar 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 20236:15 pmRNSTransaction in Own Shares
24th Mar 20235:00 pmRNSHolding(s) in Company
24th Mar 202310:00 amRNSHolding(s) in Company
23rd Mar 20236:00 pmRNSTransaction in Own Shares
22nd Mar 20236:10 pmRNSTransaction in Own Shares
22nd Mar 20233:30 pmRNSDirector/PDMR Shareholding
22nd Mar 202311:19 amRNSAnnual Financial Report 2022
21st Mar 20236:10 pmRNSTransaction in Own Shares
20th Mar 20236:20 pmRNSTransaction in Own Shares
20th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20236:15 pmRNSTransaction in Own Shares
16th Mar 20236:00 pmRNSTransaction in Own Shares
16th Mar 20235:00 pmRNSHolding(s) in Company
15th Mar 20236:25 pmRNSTransaction in Own Shares
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20239:00 amRNSDirector/PDMR Shareholding
14th Mar 20236:20 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSPlans to extend life of two nuclear power stations
13th Mar 20236:25 pmRNSTransaction in Own Shares
13th Mar 20232:00 pmRNSDirector/PDMR Shareholding
10th Mar 20236:15 pmRNSTransaction in Own Shares
10th Mar 20233:45 pmRNSHolding(s) in Company
9th Mar 20236:15 pmRNSTransaction in Own Shares
8th Mar 20236:25 pmRNSTransaction in Own Shares
7th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20234:20 pmRNSHolding(s) in Company
6th Mar 202312:50 pmRNSHolding(s) in Company
3rd Mar 20236:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.